Species |
Mouse |
Protein Construction |
CD3E & CD3D [Asp23-Asp108 (CD3E) & Phe22-Ala105 (CD3D)] Accession # P22646 (CD3E) & P04235 (CD3D) |
hFc |
N-term |
C-term |
|
Purity |
> 95% as determined by Bis-Tris PAGE
> 95% as determined by HPLC |
Endotoxin Level |
Less than 1EU per μg by the LAL method. |
Expression System |
HEK293 |
Theoretical Molecular Weight |
36.1 kDa (CD3E) and 35.2 kDa (CD3D) |
Apparent Molecular Weight |
Due to glycosylation, the protein migrates to 50-65 kDa and 40-50 kDa based on Bis-Tris PAGE result. |
Formulation |
Lyophilized from a 0.22 μm filtered solution in PBS,(pH 7.4). |
Reconstitution |
Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water. |
Storage & Stability |
Upon receiving, the product remains stable up to 6 months at -20 °C or below. Upon reconstitution, the product should be stable for 3 months at -80 °C. Avoid repeated freeze-thaw cycles. |

The purity of CD3E&CD3D hFc Chimera, Mouse is greater than 95% as determined by SEC-HPLC.

CD3E&CD3D hFc Chimera, Mouse on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.
Target Background |
T-cell surface glycoprotein CD3 epsilon & CD3 delta chain, also known as CD3E & CD3D , are single-pass type I membrane proteins.When antigen presenting cells (APCs) activate T-cell receptor (TCR), TCR-mediated signals are transmitted across the cell membrane by the CD3 chains CD3D, CD3E, CD3G and CD3Z. All CD3 chains contain immunoreceptor tyrosine-based activation motifs (ITAMs) in their cytoplasmic domain. |
Synonyms |
CD3; CD3e; CD3E; CD3d; T3D; CD3D; CD3E&CD3D; CD3 delta&CD3 epsilon |
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.